Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. - Wikidata - thesis-toulmin - TriplyDB

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

http://www.wikidata.org/entity/Q34666874

about

Inflammation and its role in age-related macular degeneration Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects Current therapeutic developments in atrophic age-related macular degeneration Tapping Stem Cells to Target AMD: Challenges and Prospects Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions NLRP3 inflammasome: activation and regulation in age-related macular degeneration Dietary supplements and disease prevention - a global overview.Dietary supplement comprised of β-carotene, vitamin C, vitamin E, and magnesium: failure to prevent music-induced temporary threshold shift.Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors.The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Cone structure in subjects with known genetic relative risk for AMD.Nutrition effects on ocular diseases in the aging eye.Age-related macular degeneration: genetics and biology coming together.Intravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trial Neuroprotectin D1 is synthesized in the cone photoreceptor cell line 661W and elicits protection against light-induced stress Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolism Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.Increased VEGF-A promotes multiple distinct aging diseases of the eye through shared pathomechanisms.The Silk-protein Sericin Induces Rapid Melanization of Cultured Primary Human Retinal Pigment Epithelial Cells by Activating the NF-κB Pathway.Increased retinal mtDNA damage in the CFH variant associated with age-related macular degeneration.Age-related macular degeneration-clinical review and genetics update.Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration.The Age-Related Macular Degeneration Complex: Linking Epidemiology and Histopathology Using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture).Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review.Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.Dietary modification and supplementation for the treatment of age-related macular degeneration.Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study.Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Drusen maculopathy: a risk factor for visual deterioration.Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials?One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

P2860

Q26768520-DCD54FA0-1324-415D-9D44-DB9D4C299BEF Q26773085-9129EC8D-7D4B-4D29-B803-9097F03D47DA Q26774188-BF4B0D46-3FA5-461A-B26B-EB58A87EA5A0 Q26778247-C25C7096-EA3F-4B88-B42C-9A2EE2758DE6 Q26799625-416281A1-82CB-4558-A616-9642EE59A80E Q26801626-5B63061A-06B5-4A50-AF4F-A118C6CC7B52 Q26823002-AD4511CE-CB24-4F9E-82DD-DAC4155B7A2A Q26995315-27592F8B-9CAA-443E-A32C-50A90B27AB8E Q30251418-4BE11AAE-67EC-4FE3-A6BC-D20B2F3A1A30 Q30368013-34E7027D-56F2-492D-9ABC-4B043D37F056 Q31151454-5C6C56A3-2994-45B3-92B9-0CAAFBC588D8 Q33702571-344BB4E2-70CF-464D-9279-9C351EC4CBDE Q33953252-B4C7A4D2-A146-42DF-BCC6-0ED7BD5747D0 Q34132062-E9616046-53E5-41CF-ACC0-F3C70EF65EC8 Q34440797-15E6B94C-AA89-41A7-A67E-C4BF3BADA502 Q34956193-70E64BFF-0335-4656-B485-6C231D5E7FAC Q35240418-FA5DAAA9-A0B1-4021-A654-178D8766880A Q35486260-BB754AA7-A60E-4972-8B75-7BD009A6D893 Q35600141-74AA02AA-5812-48DC-8B00-CB3DCD9A04EA Q35999663-A27F11BB-056D-404C-9292-2CDBFBA9BC87 Q36257030-6C7DF158-038A-4B73-A758-3108D84B8841 Q36468066-195D9B86-FAEE-4DD4-807C-48F9680EA409 Q36636094-581714A6-F008-4A44-B4B7-DCCDE16DB315 Q36651208-B5071617-CAA7-4773-823E-7A97AA453ECB Q36828352-543E79F7-AF9E-4E6A-8B2E-8B837242220A Q37068063-55162CDC-7FA8-4DF4-9440-F799B89E158C Q37296574-931631D6-A14D-4498-8FE2-96138780725B Q37412560-2E11E7A9-F378-4EC8-9717-292F1279D603 Q37592954-664A146B-8487-43EE-BB0D-BE9E590660A9 Q37702939-F1A69BB2-A0CB-4696-84BA-304CB7E3098C Q38192127-61A97B95-E870-4B95-9E8D-5D16EB436E38 Q38216031-B12EA77D-515C-4776-B6DD-D86103792FBE Q38253067-4443CF23-4329-4F6E-8583-E6B8F8DA2171 Q38529695-D56BC5ED-82A3-4CB4-A155-A657A87063BE Q38618655-A3B7BACA-1F1C-4AB1-972F-A85811DDB244 Q38653249-E69C7192-9FB9-4CBB-A81B-C634A766CD6B Q38767261-03265EE1-9080-4033-ACB2-B80511AD95D1 Q38786743-F5911F85-85EF-4F5A-B5E3-9E20B63B1D2D Q38800270-11DA68DA-0C78-47B0-9495-A264EB4823D8 Q38873518-AEA7919B-4765-41F4-964F-BA766465A61E

P2860

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

http://www.wikidata.org/entity/Q34666874

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@ast

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@en

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@nl

type

label

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@ast

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@en

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@nl

prefLabel

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@ast

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@en

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@nl

P1433

Q34666874-32D6887E-E750-480B-9F2B-E64ECAAE3D77

P1476

Q34666874-768C97F1-0D98-425D-A461-F59A1004C36A

P2093

Q34666874-23CD962B-277F-42F8-9480-F364C46B3DAD

Q34666874-A7313F04-9B70-478D-8880-3223D1D15216

Q34666874-C188D567-D07C-4F83-9EC5-A469CF519DDC

Q34666874-F7BFFAB1-B758-4DEA-88E4-D09CC8B15593

Q34666874-FC358D6A-A62A-4749-A335-E53CA360A098

P2860

Q34666874-1DB66D8A-1903-44F8-AE4A-EF36A864EA19

Q34666874-7895F026-C09E-4E18-97BE-7C38980AAC9F

Q34666874-79CD47B2-D1C6-43F9-805E-B30F790E7C5B

Q34666874-A752ADD9-EBB6-47D6-867C-BB8570196536

Q34666874-F6946E2F-0DFF-4DE8-8A35-967F416F6FE8

P304

Q34666874-6F3F1B73-EE7A-4DD4-BDC5-B280EEFF26BE

P31

Q34666874-9BF78B30-0896-4E34-BC47-B66C64312FE1

P356

Q34666874-C81F9C30-1551-4298-A12A-D8F504BD832C

P433

Q34666874-8DC813DA-F37D-4851-B30F-4E991FE6BDD7

P478

Q34666874-060B73BA-E0BA-4566-8842-65B4A60235F3

P50

Q34666874-438E4D02-747F-4325-A8FB-968F303DA5E7

Q34666874-B507425F-22E0-4931-9129-12E9798051D1

Q34666874-DC0649D1-B5FF-49EF-80F6-AE0B0E9B1025

P577

Q34666874-9585FB23-6F0D-4769-B1D5-DC06FBBA17A5

P698

Q34666874-DB97DAF9-F443-4EE0-9CBB-3D7D2FF7AD23

P921

Q34666874-1a5cd1cc-9d70-40b7-81d7-a44ee15a57cc

P932

Q34666874-C511CC2E-76A9-429F-8E73-C07717D6F753

P356

J.OPHTHA.2013.01.021

P1433

P1476

Long-term effects of vitamins ...... neration: AREDS report no. 35.

@en

P2093

John Paul Sangiovanni

http://www.w3.org/2001/XMLSchema#string

Matthew D Davis

http://www.w3.org/2001/XMLSchema#string

Natalie Kurinij

http://www.w3.org/2001/XMLSchema#string

Robert D Sperduto

http://www.w3.org/2001/XMLSchema#string

Traci E Clemons

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13

The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial

P304

1604-11.e4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2013.01.021

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Age-Related Eye Disease Study Research Group

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23582353

http://www.w3.org/2001/XMLSchema#string

P921

P932

3728272

http://www.w3.org/2001/XMLSchema#string